Contains FOS prebiotics which help the intestinal microbiota to support digestive immune system. Source of 13 vitamins high calcium and iron contact that are needed for proper growth. 0% added sugar with a homogeneous texture that babies will love.
Powder product, made with flour of toasted cereal partially hydrolyzed, with carrots. Slightly flavored with natural vanilla flavour. it is suitable for gluten free diets.
Contains FOS prebiotics which help the intestinal microbiota to support digestive immune system. Source of 13 vitamins high calcium and iron contact that are needed for proper growth. 0% added sugar with a homogeneous texture that babies will love.
Composition: Aqua, Maris Aqua (Seawater 26,8ml up to 100ml)
Indication: Daily nasal hygiene for babies, children, and adults, humidification of the nasal mucosa, and prevention of rhino-pharyngeal infections.
Composition: Aqua, Maris Aqua (Seawater)
Indication: Daily nasal hygiene for babies, children, and adults; humidification of the nasal mucosa; and prevention of rhino-pharyngeal infections.
Composition: Human Recombinant Coagulation Factor VIII 500IU Indication: Nuwiq contains the active substance human recombinant coagulation factor VIII (simoctocog alfa). Factor VIII is necessary for the blood to form clots and stop bleeding. In patients with hemophilia A (inborn factor VIII deficiency), factor VIII is missing or not working properly. Nuwiq replaces the missing factor Vlll and is used for treatment and prevention of bleeding in patients with hemophilia A and can be used for all age groups
Composition: Human immunoglobulin 10% (5g in 50ml)
Indication: Replacement therapy in primary immunodeficiency syndromes, Myeloma or chronic lymphatic leukemia with severe secondary hypogammaglobulinemia and recurrent infections and children with congenital AIDS and recurrent bacterial infections. Also has Immunomodulatory effect in Idiopathic thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgery to correct the platelet count, Guillain Barré syndrome, Kawasaki disease, Allogeneic bone marrow transplantation.
Composition: Human immunoglobulin 10g in 200ml
Indication: Replacement therapy in primary immunodeficiency syndromes, Myeloma or chronic lymphatic leukemia with severe secondary hypogammaglobulinemia and recurrent infections and children with congenital AIDS and recurrent bacterial infections. Also has Immunomodulatory effect in Idiopathic thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgery to correct the platelet count, Guillain Barré syndrome, Kawasaki disease, Allogeneic bone marrow transplantation.
Composition: Human immunoglobulin 2.5g in 50ml
Indication: Replacement therapy in primary immunodeficiency syndromes, Myeloma or chronic lymphatic leukemia with severe secondary hypogammaglobulinemia and recurrent infections and children with congenital AIDS and recurrent bacterial infections. Also has Immunomodulatory effect in Idiopathic thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgery to correct the platelet count, Guillain Barré syndrome, Kawasaki disease, Allogeneic bone marrow transplantation.
Composition: Human immunoglobulin 5% (5g in 100ml) Indication: Replacement therapy in primary immunodeficiency syndromes, Myeloma or chronic lymphatic leukemia with severe secondary hypogammaglobulinemia and recurrent infections and children with congenital AIDS and recurrent bacterial infections. Also has Immunomodulatory effect in Idiopathic thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgery to correct the platelet count, Guillain Barré syndrome, Kawasaki disease, Allogeneic bone marrow transplantation.
Composition: Human coagulation factor VIII 1000IU
Indication: Treatment and prevention of bleeding episodes in patients with hemophilia A (congenital or acquired FVIII deficiency), including previously treated patients (PTPs), previously untreated patients (PUPs) and patients undergoing major and minor surgical procedures; and for the treatment of inhibitors by Immune Tolerance Induction (ITI).
Composition: Human coagulation factor VIII 250IU
Indication: Treatment and prevention of bleeding episodes in patients with hemophilia A (congenital or acquired FVIII deficiency), including previously treated patients (PTPs), previously untreated patients (PUPs) and patients undergoing major and minor surgical procedures; and for the treatment of inhibitors by Immune Tolerance Induction (ITI).
Composition: Human coagulation factor VIII 500IU Indication: Treatment and prevention of bleeding episodes in patients with hemophilia A (congenital or acquired FVIII deficiency), including previously treated patients (PTPs), previously untreated patients (PUPs) and patients undergoing major and minor surgical procedures; and for the treatment of inhibitors by Immune Tolerance Induction (ITI).
Composition: Human Coagulation Factor IX 500IU Indication: Treatment and prophylaxis of bleeding in patients with haemophilia B (congenital factor IX deficiency).
Composition: Human prothrombin complex concentrate containing Factors II, VII, IX, X, as well as the inhibitor, protein C, and its cofactor protein S. Indication: Octaplex is used to treat and prevent bleeding caused by medicines called vitamin K antagonists (such as warfarin). Octaplex is used when rapid correction of the shortage is required in people born with a shortage of the vitamin K dependent clotting factors II and X. It is used when purified specific clotting factor product is not available.
